Signafuse Bioactive Bone Graft

Signafuse Bioactive Bone Graft fills skeletal voids or gaps that do not provide intrinsic structural stability. It combines biphasic mineral granules and 45S5 bioactive glass in a porous…

Registry build 21.09.26

Signafuse Bioactive Bone Graft fills skeletal voids or gaps that do not provide intrinsic structural stability. It combines biphasic mineral granules and 45S5 bioactive glass in a porous Type I collagen matrix.

The sterile material is mixed with the patient’s bone marrow aspirate before packing into defects of the extremities, pelvis or posterolateral spine. It provides an osteoconductive scaffold that resorbs as host bone replaces it.

Listed Item

SIGNAFUSE Bioactive Bone Graft is a bioactive bone graft substitute comprising biphasic mineral granules and 45S5 bioactive glass suspended in a porous type I collagen matrix. The device is provided sterile and is to be combined with autologous bone marrow aspirate prior to use to facilitate packing into bony defects. The device provides an osteoconductive scaffold that resorbs and guides host bone regeneration during the healing process.

Spinal Use and Supply

In the posterolateral spine, Signafuse is used as an autograft extender. Defects may be surgically created or caused by trauma. The collagen comes from bovine material, and the finished graft is sterilized by gamma irradiation.

2manufacturers in China registered for this device type
4catalogue numbers in this listing
3510(k) clearances naming this product code
1recall

Who Else Makes It

Concentrated in Shanghai (1), Beijing (1).

Chinese manufacturers registered for FDA product code MQV
Manufacturer City Province Registered as Device types
Zimmer (Shanghai) Medical International Trading Co., Ltd. Shanghai Shanghai Exporter 106
Allgens Medical Technology Co., Ltd. Beijing Beijing Complaint-file establishment 1

Record

Regulatory record for Signafuse Bioactive Bone Graft
Listed by Bioventus LLC, United States
FDA product code MQV
Device type Filler, Bone Void, Calcium Compound
Device class Class 2
Regulation 21 CFR 888.3045
Establishment Contract manufacturer, Specification developer, Repacker / relabeller, Complaint-file establishment, Manufacturer
510(k) K193513
Record published 2020-07-30

Specifications

Specifications
MRI safety Labeling does not contain MRI Safety Information
Supplied sterile Yes
Single use Yes
Prescription Prescription only
Label carries lot or batch number, expiry date
Storage Storage environment temperature 15 to 30 °C

Catalogue Numbers

Catalogue numbers for Signafuse Bioactive Bone Graft
Catalogue number Size Status
50X25X8 MM, 10 CC In distribution
100X25X8 MM, 20 CC In distribution
200X25X8 MM, 40 CC In distribution
25X25X8 MM, 5 CC In distribution

Same Product Code

Other products under the same FDA product code
Product Sold by Catalogue numbers
Synthacer medArtis Medizinprodukte und Forschung Aktiengesellschaft 360
Syntricer medArtis Medizinprodukte und Forschung Aktiengesellschaft 357
Biosorb S.B.M 65
MagnetOs Kuros Biosciences B.V 61
BioSet® Rti Surgical, Inc. 47
Bicera® Resorbable Bone Substitute Wiltrom Corporation Limited 41
GRAFTON®and Grafton PLUS®Demineralized Bone Matrix (DBM) Medtronic Sofamor Danek, Inc. 40
Bicera® Resorbable Bone Substitute Wiltrom Co., Ltd. (Chutung) 39
ChronOS Synthes Gmbh 39
Synthacer/Syntricer medArtis Medizinprodukte und Forschung Aktiengesellschaft 36
Inion BioRestore™ Inion OY 35
Resorba Synthetic Bone Biomatlante 35

Showing 12 of 750. All products under Filler, Bone Void, Calcium Compound

510(K) Clearances

FDA 510(k) clearances naming this product code
Clearance Decision date
K233490 2023-12-05
K193513 2020-06-18
K162860 2017-02-13

Recalls

1 of these is Class II. Class II means a temporary or reversible health consequence. Volume alone is not a quality signal: a manufacturer that ships more recalls more.

Recalls referencing this product code
Initiated FDA class Root cause Reason Quantity Closed
2019-02-13 Class II Package design/selection The firm became aware of the potential for the products’ sterile pouch to be punctured during transit. The packaging failure may introduce a non-sterile device that may lead to patient infection. 10,793 2020-11-02

Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.

Where China Actually Supplies

Every device page names the company that lists it and the factories registered to make the same thing. These are the sections with the most of them.

5,100manufacturers registered in China
2,581device types they are registered for
340,248device records, each naming its maker
31provinces with a registered manufacturer